Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


15.10.2018

1 Dig Dis Sci
1 Gastroenterol Hepatol
1 Gastroenterology
1 Gut
1 Hepatology
8 J Hepatol
1 J Infect Dis
1 J Med Virol
1 J Virol
1 N Engl J Med
7 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Dig Dis Sci

  1. KHALILI M, Wong RJ
    Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net.
    Dig Dis Sci. 2018 Oct 11. pii: 10.1007/s10620-018-5316.
    PubMed     Text format    


    Gastroenterol Hepatol

  2. MADUELL F, Belmar L, Ugalde J, Laguno M, et al
    Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.
    Gastroenterol Hepatol. 2018 Oct 4. pii: S0210-5705(18)30252.
    PubMed     Text format     Abstract available


    Gastroenterology

  3. O'BRIEN TR, Yang HI, Groover S, Jeng WJ, et al
    Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression.
    Gastroenterology. 2018 Oct 1. pii: S0016-5085(18)35083.
    PubMed     Text format     Abstract available


    Gut

  4. YANG HC, Kao JH
    Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus.
    Gut. 2018 Oct 9. pii: gutjnl-2018-317385. doi: 10.1136/gutjnl-2018-317385.
    PubMed     Text format    


    Hepatology

  5. PARK H, Wang W, Henry L, Nelson DR, et al
    Impact of all-oral direct-acting antivirals on clinical and economic outcomes in chronic hepatitis C patients in the U.S.
    Hepatology. 2018 Oct 5. doi: 10.1002/hep.30303.
    PubMed     Text format     Abstract available


    J Hepatol

  6. ROSS DB, Belperio PS, Chartier M, Backus LI, et al
    Hepatitis C Testing in U.S. Veterans Born 1945-1965: An Update.
    J Hepatol. 2016 Oct 5. pii: S0168-8278(16)30557.
    PubMed     Text format    

  7. JUSTICE AC, Esserman D, Sarkar S, Levin FL, et al
    Reply to: "Disparities in Hepatitis C Testing in U.S. Veterans Born 1945-1965".
    J Hepatol. 2016 Oct 4. pii: S0168-8278(16)30558.
    PubMed     Text format    

  8. FALADE-NWULIA O, Sulkowski M
    The HCV care continuum does not end with cure: A call to arms for the prevention of reinfection.
    J Hepatol. 2016 Nov 2. pii: S0168-8278(16)30636.
    PubMed     Text format    

  9. TSAI PC, Huang CF, Yu ML
    Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: issue of tie interval between HCC treatment and antiviral therapy.
    J Hepatol. 2016 Nov 10. pii: S0168-8278(16)30646.
    PubMed     Text format    

  10. HELLARD M, Pedrana A, Scott N
    Targeted direct-acting antiviral treatment for chronic hepatitis C: a financial reality or an obstacle to elimination?
    J Hepatol. 2016 Nov 21. pii: S0168-8278(16)30680.
    PubMed     Text format    

  11. VUKOTIC R, Conti F, Andreone P
    Hepatitis C virus eradication in elderly: The challenge worth a long-life elixir?
    J Hepatol. 2016 Dec 21. pii: S0168-8278(16)30745.
    PubMed     Text format    

  12. KLAG T, Dietz J, Werner CR, Schwarz JM, et al
    Hepatitis C "true" late relapse beyond 48 weeks of sustained virologic response after direct acting antiviral therapy.
    J Hepatol. 2017 Jan 9. pii: S0168-8278(17)30006.
    PubMed     Text format    

  13. NGUYEN MH, Ozbay AB, Liou I, Meyer N, et al
    Healthcare Resource Utilization and Costs by Disease Severity in an Insured National Sample of US Patients with Chronic Hepatitis B.
    J Hepatol. 2018 Oct 1. pii: S0168-8278(18)32440.
    PubMed     Text format     Abstract available


    J Infect Dis

  14. TURPIN J, Yurick D, Khoury G, Pham H, et al
    Impact of Hepatitis B Virus Coinfection on Human T-Lymphotropic Virus Type 1 Clonality in an Indigenous Population of Central Australia.
    J Infect Dis. 2018 Oct 11. pii: 5126831. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  15. YANG H, Wu J, Yuan Y, Huang W, et al
    Retrospectively Seroprevalence Study on Anti-HEV-IgG antibody in patients with chronic hepatitis or liver cirrhosis in a Chinese teaching hospital.
    J Med Virol. 2018 Oct 11. doi: 10.1002/jmv.25335.
    PubMed     Text format     Abstract available


    J Virol

  16. BAI L, Zhang X, Li W, Wu M, et al
    Extracellular HBV RNAs are heterogeneous in length and circulate as capsid-antibody-complexes in addition to virions in chronic hepatitis B patients.
    J Virol. 2018 Oct 3. pii: JVI.00798-18. doi: 10.1128/JVI.00798.
    PubMed     Text format     Abstract available


    N Engl J Med

  17. FUSTER D, Samet JH
    Alcohol Use in Patients with Chronic Liver Disease.
    N Engl J Med. 2018;379:1251-1261.
    PubMed     Text format    


    PLoS One

  18. UCHIDA Y, Naiki K, Kouyama JI, Sugawara K, et al
    Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy.
    PLoS One. 2018;13:e0205600.
    PubMed     Text format     Abstract available

  19. SOSA-JURADO F, Melendez-Mena D, Rosas-Murrieta NH, Guzman-Flores B, et al
    Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients.
    PLoS One. 2018;13:e0205356.
    PubMed     Text format     Abstract available

  20. DA SILVA EN, Baker A, Alshekaili J, Karpe K, et al
    A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.
    PLoS One. 2018;13:e0204477.
    PubMed     Text format     Abstract available

  21. JUANBELTZ R, Martinez-Baz I, San Miguel R, Goni-Esarte S, et al
    Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.
    PLoS One. 2018;13:e0205277.
    PubMed     Text format     Abstract available

  22. SCHNELL G, Krishnan P, Tripathi R, Beyer J, et al
    Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.
    PLoS One. 2018;13:e0205186.
    PubMed     Text format     Abstract available

  23. FAHMY AM, Khabir M, Blanchet M, Labonte P, et al
    LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication.
    PLoS One. 2018;13:e0205189.
    PubMed     Text format     Abstract available

  24. TAKAHASHI A, Moriya K, Ohira H, Arinaga-Hino T, et al
    Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
    PLoS One. 2018;13:e0204772.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: